Triple-Negative Breast Cancers: Different Sensitivity to Chemotheray

被引：0
|
作者：
Choi, Y. L.
Oh, E.
Kim, Y.
Park, Y. H.
Cho, E. Y.
Lee, J. E.
Kim, J. H.
Nam, S. J.
Lim, Y. H.
Yang, J. H.
Shin, Y. K.
Hong, Y. C.
机构：
[1] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea
[2] Natl Canc Ctr, Goyang, South Korea
[3] Seoul Natl Univ, Coll Pharm, Seoul, South Korea
[4] Seoul Natl Univ, Coll Med, Seoul, South Korea
来源：
MODERN PATHOLOGY | 2010年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
173
引用
下载
收藏
页码：41A / 41A
页数：1
相关论文
共 50 条
  • [31] Efavirenz as a potential drug for the treatment of triple-negative breast cancers
    P.-T. Chiou
    S. Ohms
    P. G. Board
    J. E. Dahlstrom
    D. Rangasamy
    M. G. Casarotto
    Clinical and Translational Oncology, 2021, 23 : 353 - 363
  • [32] Classification of triple-negative breast cancers based on Immunogenomic profiling
    He, Yin
    Jiang, Zehang
    Chen, Cai
    Wang, Xiaosheng
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2018, 37
  • [33] Predicting response to platinum agents in triple-negative breast cancers
    Brown, Emily
    PERSONALIZED MEDICINE, 2014, 11 (05) : 468 - 468
  • [34] TTK: A novel target for radiosensitization in triple-negative breast cancers
    Chandler, Benjamin C.
    Moubadder, Leah
    Ritter, Cassie
    Niknafs, Yashar
    Olsen, Eric
    Cameron, Meleah
    Liu, Meilan
    Wilder-Romans, Kari
    Nyati, Shyam
    Brown, Powel
    Chinnaiyan, Arul
    Speers, Corey
    CANCER RESEARCH, 2018, 78 (13)
  • [35] Triple-Negative Breast Cancers: Unique Clinical Presentations and Outcomes
    Billar, Julie A. Y.
    Dueck, Amylou C.
    Stucky, Chee-Chee H.
    Gray, Richard J.
    Wasif, Nabil
    Northfelt, Donald W.
    McCullough, Ann E.
    Pockaj, Barbara A.
    ANNALS OF SURGICAL ONCOLOGY, 2010, 17 : S384 - S390
  • [36] Targeting a cell state common to triple-negative breast cancers
    Muellner, Markus K.
    Mair, Barbara
    Ibrahim, Yasir
    Kerzendorfer, Claudia
    Lechtermann, Hannelore
    Trefzer, Claudia
    Klepsch, Freya
    Mueller, Andre C.
    Leitner, Ernestine
    Macho-Maschler, Sabine
    Superti-Furga, Giulio
    Bennett, Keiryn L.
    Baselga, Jose
    Rix, Uwe
    Kubicek, Stefan
    Colinge, Jacques
    Serra, Violeta
    Nijman, Sebastian M. B.
    MOLECULAR SYSTEMS BIOLOGY, 2015, 11 (02)
  • [37] Pathway Analysis of Primary Human Triple-Negative Breast Cancers
    Ossovskaya, V.
    Xu, Q.
    Lituev, A.
    Potapova, O.
    Monforte, J.
    Daraselia, N.
    CANCER RESEARCH, 2010, 70
  • [38] GATA3 expression in triple-negative breast cancers
    Byrne, David J.
    Deb, Siddhartha
    Takano, Elena A.
    Fox, Stephen B.
    HISTOPATHOLOGY, 2017, 71 (01) : 63 - 71
  • [39] Imputing a more targeted therapy for triple-negative breast cancers
    Gruener, Robert F.
    Greene, Geoffrey L.
    Huang, R. Stephanie
    CLINICAL CANCER RESEARCH, 2020, 26 (12) : 25 - 26
  • [40] Efavirenz as a potential drug for the treatment of triple-negative breast cancers
    Chiou, P-T
    Ohms, S.
    Board, P. G.
    Dahlstrom, J. E.
    Rangasamy, D.
    Casarotto, M. G.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2021, 23 (02): : 353 - 363
12345